Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Head and Neck Cancer

  Free Subscription

Articles published in Hum Pathol

Retrieve available abstracts of 22 articles:
HTML format

Single Articles

    May 2023
  1. NG JKM, Li JJX, Lai BSW, Tsang JY, et al
    WT1 as a myoepithelial marker: a comparative study of breast, cutaneous, and salivary gland lesions.
    Hum Pathol. 2023;135:76-83.
    PubMed     Abstract available

    April 2023
  2. GUBBIOTTI MA, Andrianus S, Sakhi R, Zhang Q, et al
    Does the Presence of Capsule Influence Prognosis in Poorly-Differentiated Thyroid Carcinoma?
    Hum Pathol. 2023 Apr 11:S0046-8177(23)00084.
    PubMed     Abstract available

  3. HUANG H, Li L, Liu X, Zhao L, et al
    Papillary thyroid carcinoma with desmoid-type fibromatosis: the clinicopathological features with characteristic imaging and molecular correlation requiring comprehensive treatment.
    Hum Pathol. 2023 Apr 3:S0046-8177(23)00079-5. doi: 10.1016/j.humpath.2023.
    PubMed     Abstract available

  4. WANG L, Wang XT, Fang Y, Qiu W, et al
    Thyroid-like low-grade nasopharyngeal papillary adenocarcinoma: a clinicopathological and molecular study of four cases.
    Hum Pathol. 2023;134:66-73.
    PubMed     Abstract available

    December 2022
  5. INOUE A, Matsumoto T, Ito Y, Saegusa M, et al
    TP53 positivity combined with high fibrinogen expression defines a subtype of oral squamous cell carcinoma with an unfavorable prognosis.
    Hum Pathol. 2022;130:25-35.
    PubMed     Abstract available

    September 2022
  6. SHI Q, Zhang B, Bsirini C, Li L, et al
    NR4A3 fluorescence in situ hybridization analysis in cytologic and surgical specimens of acinic cell carcinoma.
    Hum Pathol. 2022;127:86-91.
    PubMed     Abstract available

    August 2022
  7. KIM E, Chung M, Jeong HS, Baek CH, et al
    Histological features of differentiated dysplasia in the oral mucosa: a review of oral invasive squamous cell carcinoma cases diagnosed with benign or low-grade dysplasia on previous biopsies.
    Hum Pathol. 2022;126:45-54.
    PubMed     Abstract available

  8. ABREU RF, Oliveira TB, Hertzler H, Toledo RN, et al
    NUT carcinoma, an under-recognized malignancy: a clinicopathologic and molecular series of 6 cases showing a subset of patients with better prognosis and a rare ZNF532::NUTM1 fusion.
    Hum Pathol. 2022;126:87-99.
    PubMed     Abstract available

    May 2022
  9. GAO Y, Wang P, Lu J, Pan B, et al
    Diagnostic significance of parafibromin expression in parathyroid carcinoma.
    Hum Pathol. 2022 May 30. pii: S0046-8177(22)00141.
    PubMed     Abstract available

  10. SUN L, Petrone JS, McNulty SN, Evenson MJ, et al
    Comparison of gene fusion detection methods in salivary gland tumors.
    Hum Pathol. 2022;123:1-10.
    PubMed     Abstract available

    February 2022
  11. MURASE T, Ishibashi K, Okumura Y, Ueda K, et al
    Pleomorphic adenoma: detection of PLAG1 rearrangement-positive tumor components using whole-slide fluorescence in situ hybridization.
    Hum Pathol. 2022;120:26-34.
    PubMed     Abstract available

    December 2021
  12. MOLLIGAN JF, Powell GM, Wenger DE, Torres-Mora J, et al
    Sternoclavicular Joint Pseudotumor: A Clinicopathologic and Radiologic Study of 25 Cases Occurring in Patients Without Prior Neck Dissection.
    Hum Pathol. 2021 Dec 27. pii: S0046-8177(21)00217.
    PubMed     Abstract available

    October 2021
  13. TASHAKORI M, Kim DH, Kanagal-Shamanna R, Vega F, et al
    Mantle Cell Lymphoma Involving Tonsils: A Clinicopathologic Study of 83 Cases.
    Hum Pathol. 2021 Oct 13. pii: S0046-8177(21)00179.
    PubMed     Abstract available

    August 2021
    Somatostatin receptor 2 (SSTR2) is highly sensitive and specific for Epstein-Barr Virus-associated nasopharyngeal carcinoma.
    Hum Pathol. 2021 Aug 17. pii: S0046-8177(21)00147.
    PubMed     Abstract available

  15. LAM AK, Bourke MJ, Chen R, Fiocca R, et al
    Dataset for the reporting of carcinoma of the esophagus in resection specimens: recommendations from the International Collaboration on Cancer Reporting.
    Hum Pathol. 2021;114:54-65.
    PubMed     Abstract available

  16. FISCH AS, Laklouk I, Nakaguro M, Nose V, et al
    Intraductal carcinoma of the salivary gland with NCOA4-RET: expanding the morphologic spectrum and an algorithmic diagnostic approach.
    Hum Pathol. 2021;114:74-89.
    PubMed     Abstract available

  17. GUBBIOTTI MA, Livolsi V, Montone K, Baloch Z, et al
    Papillary thyroid microcarcinomas: does subtyping predict aggressive clinical behavior?
    Hum Pathol. 2021;114:28-35.
    PubMed     Abstract available

    May 2021
  18. GUBBIOTTI MA, Montone K, Zhang P, Livolsi V, et al
    A contemporary update on hyalinizing clear cell carcinoma: compilation of all in-house cases at our institution and a literature review spanning 2015-2020.
    Hum Pathol. 2021;111:45-51.
    PubMed     Abstract available

    April 2021
  19. GHOSSEIN R, Barletta JA, Bullock M, Johnson SJ, et al
    Data set for reporting carcinoma of the thyroid: recommendations from the International Collaboration on Cancer Reporting.
    Hum Pathol. 2021;110:62-72.
    PubMed     Abstract available

    March 2021
  20. YAMAMOTO H, Nozaki Y, Sugii A, Taguchi K, et al
    Pan-tropomyosin receptor kinase immunoreactivity, ETV6-NTRK3 fusion subtypes, and RET rearrangement in salivary secretory carcinoma.
    Hum Pathol. 2021;109:37-44.
    PubMed     Abstract available

    February 2021
  21. SALIBA G, Detlefsen S, Carneiro F, Conner J, et al
    Tumor regression grading after neoadjuvant treatment of esophageal and gastroesophageal junction adenocarcinoma: results of an international Delphi consensus survey.
    Hum Pathol. 2021;108:60-67.
    PubMed     Abstract available

  22. LAM AK
    Updates on World Health Organization classification and staging of esophageal tumors: implications for future clinical practice.
    Hum Pathol. 2021;108:100-112.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.